Acarix News Today

The extra general meeting of Acarix AB was held today on 9 June 2023 and the following resolutions were passed by the meeting. Resolution to approve the board of directors resolution to issue new... | June 9, 2023

In December 2022, Acarix AB carried out a rights issue of shares and warrants of series 2022:U . The exercise period for the warrants ran from and including May 2, 2023 up to and including May 16,... | May 22, 2023

The shareholders of Acarix AB, reg. no. 559009-0667, are hereby convened to the annual general meeting to be held on Thursday 11 May 2023 at 10.00 AM at the Baker & McKenzie Advokatbyrås... | April 11, 2023

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced a strategic sales partnership with CompleMed, LLC, a national sales organization

With effect from December 16, 2022, the unit rights in Acarix AB will be traded on First North Premier Growth Market. Trading will continue up until and including December 27, 2022. Instrument: Unit

Press release Malmö, Sweden, June 22, 2022 Acarix partners with Strategic Health AK to roll-out CADScorSystem across the state of Alaska Acarix continues its US expansion by partnering with Strategic

Press release Malmö, Sweden, June 10, 2022 Acarix signs additional commercial agreement in US and receives order for CADScorSystem in Louisiana. Acarix continues the US expansion with another commercial

Press release Malmö, Sweden, June 3, 2022 Acarix signs additional commercial agreement in US and receives rapid orders in both Mississippi and Tennessee Acarix today announces an additional commercial

Press release Malmö, Sweden, May 11, 2022 Announcement from Acarix's annual general meeting The annual general meeting 2022 ("AGM") of Acarix AB ("Acarix" or the "Company") was held today on

Press release Malmö, Sweden, May 11, 2022 Acarix AB (publ) publishes Interim Report, January - March 2022 Increased commercial momentum and great interest in CADScor System on the US market2022